Lipoprotein profile in girls with asymptomatic hyperuricemia

To investigate the relation between uricemia and lipid profile, 539 Arkhangelsk schoolgirls aged 7-17 were examined. With upper norm limit of 0. 31 mmol/l, the prevalence of asymptomatic chronic hyperuricemia among Arkhangelsk girls was as high as 25 %. With uricemia higher than 0. 31 mmol/l, total...

Full description

Saved in:
Bibliographic Details
Main Authors: S. I. Maljavskaya, T. A. Toropygina, V. E. Tril, V. A. Ternovskaya
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2004-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1857
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To investigate the relation between uricemia and lipid profile, 539 Arkhangelsk schoolgirls aged 7-17 were examined. With upper norm limit of 0. 31 mmol/l, the prevalence of asymptomatic chronic hyperuricemia among Arkhangelsk girls was as high as 25 %. With uricemia higher than 0. 31 mmol/l, total cholesterol, triglycerides, LDL cholesterol levels were significantly elevated. Mean total cholesterol levels in such individuals were higher than WHO norms of normocholesterolemia for children and adolescents. From the other hand, among individuals with dyslipidemia, uricemia more than 0. 31 mmol/l was diagnosed significantly more frequently. All measured lipid and liporotein parameters directly correlated with uricemia level, and inversely correlated with urate excretion rate, regardless of pathogenetic hyperuricemia mechanisms. Our results point to the fact that chronic hyperuricemia is assosiated with atherogenic lipid/lipoprotein phenotype, observed as early as in childhood, and possibly acts as an indicator of atherosclerosis risk. Therefore, use of a lower norm for population screening seems rational, from position of primary and secondary prevention of atherosclerosis. Our data support detailed examination of lipid metabolism if uricemia is higher than 0. 31 mmol/l.
ISSN:1560-4071
2618-7620